Nicoderm CQ

GPTKB entity

Statements (50)
Predicate Object
gptkbp:instanceOf gptkb:beer
gptkbp:advises 8 to 12 weeks
gptkbp:availableIn transdermal patch
gptkbp:clinicalTrials effective in long-term cessation
improves quit rates
shown to reduce cravings
gptkbp:contains nicotine
gptkbp:contraindication pregnancy
breastfeeding
allergy to nicotine
gptkbp:dosageForm patches
gptkbp:healthcare do not exceed recommended dose
follow instructions on the package
consult_healthcare_provider_if_symptoms_persist
https://www.w3.org/2000/01/rdf-schema#label Nicoderm CQ
gptkbp:interactsWith alcohol
certain medications
caffeine
gptkbp:manufacturer gptkb:Johnson_&_Johnson
gptkbp:offersCoursesIn gptkb:Australia
gptkb:Brazil
gptkb:Canada
gptkb:France
gptkb:Germany
gptkb:India
gptkb:Japan
gptkb:Mexico
gptkb:United_Kingdom
gptkb:United_States
gptkbp:services once daily
gptkbp:sideEffect dizziness
headache
nausea
skin irritation
insomnia
gptkbp:skills 7 mg
14 mg
21 mg
gptkbp:storage room temperature
away from moisture
gptkbp:symptoms anxiety
irritability
difficulty concentrating
increased appetite
cravings
gptkbp:takesPlaceIn arm
upper body
gptkbp:usedFor smoking cessation
gptkbp:waterManagement keep out of reach of children
dispose in household trash